Stryker Corporation $SYK Shares Purchased by Vinva Investment Management Ltd

Vinva Investment Management Ltd increased its position in shares of Stryker Corporation (NYSE:SYK) by 38.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 28,803 shares of the medical technology company’s stock after acquiring an additional 7,932 shares during the period. Vinva Investment Management Ltd’s holdings in Stryker were worth $10,654,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Armstrong Advisory Group Inc. lifted its position in shares of Stryker by 12.3% during the third quarter. Armstrong Advisory Group Inc. now owns 247 shares of the medical technology company’s stock worth $91,000 after purchasing an additional 27 shares in the last quarter. Venturi Wealth Management LLC increased its holdings in Stryker by 1.4% during the 3rd quarter. Venturi Wealth Management LLC now owns 1,904 shares of the medical technology company’s stock worth $704,000 after purchasing an additional 27 shares during the period. Patriot Financial Group Insurance Agency LLC raised its position in Stryker by 3.9% in the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 745 shares of the medical technology company’s stock valued at $275,000 after purchasing an additional 28 shares in the last quarter. Wolff Wiese Magana LLC grew its position in shares of Stryker by 2.3% during the third quarter. Wolff Wiese Magana LLC now owns 1,271 shares of the medical technology company’s stock worth $470,000 after buying an additional 28 shares in the last quarter. Finally, Enterprise Financial Services Corp increased its stake in shares of Stryker by 4.3% during the second quarter. Enterprise Financial Services Corp now owns 705 shares of the medical technology company’s stock worth $279,000 after buying an additional 29 shares during the period. 77.09% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have weighed in on SYK shares. Robert W. Baird set a $437.00 price target on Stryker in a research note on Friday, January 30th. Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 price objective for the company in a research report on Tuesday, January 6th. UBS Group raised their target price on Stryker from $386.00 to $400.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 24th. Jefferies Financial Group restated a “buy” rating and set a $465.00 price objective on shares of Stryker in a research report on Wednesday. Finally, Needham & Company LLC upped their target price on shares of Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a report on Friday, January 30th. Fourteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $428.61.

Insider Buying and Selling

In related news, Director Ronda E. Stryker sold 250,000 shares of the business’s stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the sale, the director owned 2,457,331 shares of the company’s stock, valued at approximately $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 5.20% of the company’s stock.

Stryker Trading Down 1.7%

Shares of Stryker stock opened at $364.11 on Monday. The firm has a market cap of $139.34 billion, a price-to-earnings ratio of 43.35, a price-to-earnings-growth ratio of 2.13 and a beta of 0.85. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $404.87. The company’s 50-day simple moving average is $365.45 and its 200-day simple moving average is $368.84. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, beating analysts’ consensus estimates of $4.40 by $0.07. The firm had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The firm’s revenue was up 11.4% compared to the same quarter last year. During the same quarter last year, the firm earned $4.01 earnings per share. As a group, equities research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a $0.88 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. Stryker’s dividend payout ratio (DPR) is 41.90%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.